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Background: Ulcerative colitis (UC) is uncommon in the tropics and sub-tropics. We report a case of UC in a 7 year
old girl whose parents were both Nigerians. This report is to alert healthcare professionals in sub-Saharan Africa that
UC is not a rare health problem, especially in children.
Case presentation: The patient presented with frequent passage of blood stained stool, abdominal pain and
significant weight loss. The diagnosis was entertained after she was investigated for common causes of chronic
diarrhea in our setting and the findings were negative. The patient symptoms abated after she was commenced on
steroid therapy.
Conclusion: Under-diagnosis and misdiagnosis may account for a dearth of information on UC in African children.
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Ulcerative colitis (UC) is a chronic inflammatory disease
of unknown aetiology, localized to the colon and spares
the upper gastrointestinal tract [1]. The inflammation is
characteristically remitting and relapsing [2].
The prevalence of UC varies across geographical zones
and from one country to another [3]. In North America,
the prevalence varies from 37.5 to 238 per 100000 people
[4]. The disease is less common in children than adults [2].
In patients with UC, 20% are younger than 20 years of age,
4% are children aged less than 5 years and 1% are infants
[3,5]. Although, UC can occur at any age, the incidence
peak in age group 15–25 years and in 55–65 years [6]. The
first paediatric case was reported in 1923 by Helmholz [7],
thereafter, several other cases have been reported in chil-
dren [8-10]. UC usually exists in isolation and together
with Crohn’s disease (CD) and indeterminate colitis (IC)
constitutes a genetically, immunologically and histopatho-
logically heterogeneous group of inflammatory bowel dis-
orders called inflammatory bowel disease (IBD) [11]. Very
rarely are these diseases diagnosed in the same patient* Correspondence: senbanjo001@yahoo.com
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reproduction in any medium, provided the or[12]. However, a rare case of UC co-exiting with CD had
been reported in an adult [13].
Many familial cases have been reported in the United
States, yet no simple Mendelian genetic mechanism has
been able to explain its transmission in those with asso-
ciated family history of the disease [2]. The prevalence of
UC is highest in Europe and America among Caucasians
and Ashkenazic Jews and lowest in black Americans and in
African countries and Japan [1]. Although, cases of UC in
African-American children living in the United States of
America have been reported [14], none has been reported
in Africa. The rarity of the disease in Africa may limit the
experience of clinicians in its diagnosis and management,
especially in children. This case is therefore reported to
create an awareness of UC among paediatric age group
and to discuss the challenges facing the diagnosis and
management of the disease in a resource poor country.
Case presentation
A 7 year old girl presented to the paediatric gastroenter-
ology clinic at the Lagos State University Teaching Hospital
(LASUTH), Ikeja with a history of prolonged diarrhoea of
10 weeks that progressed to frank haematochezia 2 weeks
later. She also presented with abdominal pain weight loss of
over 8 weeks duration. Stool was initially watery, not offen-
sive or mucoid. Bowel motions were about 10 times per
day. There was no vomiting, fever, jaundice, mouth ulcer or
joint pains. The abdominal pain was crampy, diffuselyral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Barium enema showed dilatation of the sigmoid and
descending colon, persistent narrowing of the rectum with
effacement of the mucosal pattern that was replaced by thumb
printing appearances.
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neither aggravated nor relieved by any known factors. Pain
did not radiate elsewhere nor, disturb the patient from
sleep, associate with tenesmus or abdominal distension.
The symptoms were however associated with a significant
weight loss despite good appetite and adequate feeding.
There were no associated respiratory and urinary symp-
toms. The past medical history was remarkable in the sense
that she had initially presented to a general hospital where
she was investigated and treated for dysentery with a course
of metronidazole, co-trimoxazole and hyoscine bromide for
6 weeks without any appreciable improvement. There was
no history or signs of past abdominal surgery. Patient is the
first of three children to both monogamous parents. The
parents are Nigerians and there was no history of similar ill-
ness in any member of the family.
On examination, she was afebrile, anicteric, mildly
pale, weighed 19kg, not irritable or in respiratory dis-
tress, not dehydrated or had peripheral oedema. There
was no peripheral lymphadenopathy, skin desquamation
or skin discolorations. The mucous membranes and
nails were normal. Mild tenderness was elicited in the
peri-umbillical region but no palpable abdominal mass,
hepatomegaly or splenomegaly. Rectal examination was
painful, no palpable rectal mass. The rectum appeared
to be narrowed and the examination finger was stained
with frank blood.
The patient was admitted and investigated for causes
of lower gastrointestinal bleeding. The investigations
revealed Hb of 10g/dL, white blood cell count of 19,400/
mm3 with neutrophil differential of 61%, lymphocyte-32%
and monocyte-7%. The ESR was elevated to 34mm/hr and
serum protein significantly reduced with hypoalbuminae-
mia of 21g/dL. The liver function test and electrolyte with
urea were essentially normal. The stool and urine cultures
yielded no growth after 48 hours of incubation. No eggs,
ova or intestinal parasites were seen on stool microscopy.
Patient was commenced on a high protein diet and all
antibiotics discontinued for 10 days. While the symptoms
persisted, barium enema was requested which showed
dilatation of the sigmoid and descending colon in associ-
ation with persistent narrowing of the rectum and efface-
ment of the mucosal pattern that was replaced by thumb
printing appearances (Figure 1). These findings were sug-
gestive of UC. Colonoscopy and rectal biopsy were per-
formed later. The colonoscopy showed inflammatory
changes extending from the anal opening up to the visible
part of the descending colon. The bowel mucosa was
erythemous and oedematous, with effaced vascular pat-
tern. Tissue biopsy was granular and friable. The histology
of the rectal tissue biopsy confirmed UC as shown in
Figure 2.
Patient was commenced on sulfasalazine 50mg/kg/day
in two divided doses and gradually increased to 60mg/kg/day after a week treatment as it was well tolerated.
Patient was in remission until 6 months follow up. How-
ever, she defaulted from the clinic for about 6 months
but continued taking her medications at home for an-
other 5 months. She presented again with bleeding diar-
rhoea after stopping her medications for about a month.
Sulfasalazine was re-commenced at the same dose plus
prednisolone 1 mg/kg/day in two divided doses. Patient
responded very well to the new regime and now in re-
mission. She is being followed at the outpatient clinic
every 4 weeks.
Discussion
UC is known to affect children and adults globally. How-
ever, it is less common in Africa probably due to under-
diagnosis, misdiagnosis or low racial distribution. Few
Figure 2 Photomicrograph of UC (rectal mucosa) showing
intense inflammation with disordered crypts and evidence of
cryptitis and crypt abscess. H & E (magnification x 200).
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[15], Uganda [16] and Sudan [17]. Lack of reported cases
in African children therefore underscores the import-
ance of this current case report.
A major challenge in the management of UC in devel-
oping countries is making an accurate diagnosis. Our
patient was presumptively treated for amoebic dysentery
at a general hospital. In spite of persistent symptoms
after 6 weeks of antibiotic therapy, UC was not sus-
pected by her physician. Thus, a high index of suspicion
may be required for early diagnosis of UC which should
be considered as a differential diagnosis of blood stained
chronic diarrhoeal diseases in children.
Presently, there is no permanent medical cure for UC
[1,2]. The general goals of treatment in children are to
control symptoms of the disease with minimal adverse
effects of the medicines used and to achieve normal
functioning of the patient [1,2]. A multidisciplinary ap-
proach has been suggested for effective management of
UC in children [2]. Patient should be treated and fol-
lowed up jointly by a team consisting of a paediatric
gastroenterologist, paediatric surgeon, child psychiatrist,
clinical psychologist and social worker. The intensity of
treatment is dependent on the severity of the disease [1].
Less than 5% of children with UC may present pred-
ominantly with extraintestinal manifestations, such as
growth failure; arthropathy; dermatological, genitourin-
ary or pulmonary manifestations; coagulopathy; or liver
disease [1,2]. However, none of these symptoms was
manifested in the patient. Based on the symptoms and
signs of bloody diarrhoea, abdominal cramps, urgency to
defecate, abdominal tenderness, weight loss and mild
anemia at presentation, and colonoscopy with histologic
findings, the patient was diagnosed of moderate UC [2].
Mild to moderate UC is usually treated on an outpatientbasis. Admission becomes inevitable upon failure of
maximal outpatient therapy or progression to severe dis-
ease [1,2].
The patient was managed on outpatient basis after ini-
tial investigation and stabilization on admission. She was
commenced on paediatric medical regimen for UC con-
sisting of low residue diet, antimotility and sulfasalazine
(a first line medicine) [1,2]. Sulfasalazine is known to
treat UC effectively and prevents recurrence [1,2]. Its
prolonged use, even during remission, has been recom-
mended in children [1]. However, hypersensitivity ad-
verse reaction to the sulfa component of sulfasalazine is
a major limitation to its use as a first line medicine
which may occur in 10-20% of patients [2]. Fortunately,
the medicine was well tolerated by the patient. On rare
occasions, sulfasalazine can exacerbate the symptoms
and signs of UC which may prompt patient to self dis-
continue the medication. On the contrary, there was a
tremendous improvement in the patient following the
use of sulfasalazine. The medication was self discontin-
ued as both the patient and the parents felt a permanent
cure had been achieved after 11 months of remission.
Lack of adequate counseling and psychosocial support
might have contributed to the poor drug compliance
exhibited by the patient at a later stage of treatment.
The role of a clinical psychologist is to promote the
psychological wellbeing of the patient and enable her to
adjust to her daily normal life activities. The multidiscip-
linary approach to managing this type of patients is im-
portant and equally necessary when managing other
chronic childhood illness. Unfortunately, the number of
clinical psychologists and social workers in Nigeria is
just a handful and are confined to academic institutions
and tertiary health care facility.
Prednisolone is a second line medicine that was included
in the treatment when the patient re-presented to our hos-
pital. The use was justified by the slow response to sulfa-
salazine. However, both medicines were able to abate the
symptoms and signs of the recurrent UC without any ad-
verse effects. Corticosteroids are known to control acute
flares of UC effectively but less effective at maintaining
long term remission [2,18]. The numerous adverse effects
of prolong use of corticosteroids also preclude their main-
tenance use during UC remission. We, therefore plan to
taper off the dose of prednisolone over time and maintain
the patient on sulfasalazine after achieving a prolonged
remission.
Clinic default and poor medication compliance is a
common problem of children with chronic diseases [19].
Poor follow-up has been reported in South African adults
with UC [14]. Further default and poor medication com-
pliance may put the patient at risks of progressing to ful-
minant colitis or becoming refractory to medical therapy
[1,2]. Approximately 5-10% of such patients may require
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ever, be seen as a complementary to medical therapy and
as a means of preventing complications [20].
Conclusion
This is the first time UC is reported in an African child.
Under-diagnosis and misdiagnosis may have accounted
for lack of reports on this subject from Africa. Ingenuity
may therefore be required for early diagnosis. UC should
be suspected in childhood bloody chronic diarrhoeal dis-
eases and patient should be investigated as such. Opti-
mal management is required to achieve long term
remission on medical therapy with minimal adverse
effects.
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